Blood Clots, Deep Vein Thrombosis (DVT) & Pulmonary Embolism

What is Pulmonary Embolism? (Canadian Lung Association)
Discusses pulmonary embolism, its causes, symptoms, diagnosis, and treatment. [10/06]

Pulmonary Embolism (emedicine.com)
Comprehensive discussion of pulmonary embolism. Aimed at physicians. [4/03]

Warfarin vs Low-Molecular-Weight Heparin Therapy in Cancer Patients (The Oncologist)
Comprehensive article in the January 2005 issue of The Oncologist that addresses the issue of venous thromboembolism (VTE) in cancer patients. Discusses current treatments and elucidates the advantages and disadvantages of treatment with warfarin (Coumadin) as compared to low-molecular-weight heparins such as dalteparin (Fragmin). [1/05]

Low-molecular-weight Heparin vs Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (PubMed)
Abstract of a study published in the July 10, 2003 issue of the New England Journal of Medicine that compared the efficacy of a low-molecular-weight heparin with that of an oral anticoagulant agent in preventing recurrent thrombosis in patients with cancer. Study concluded that in patients with cancer and acute venous thromboembolism, dalteparin was more effective than oral anticoagulant in reducing the risk of recurrent thromboembolism without increasing the risk of bleeding. [7/03]

Prospective Evaluation of Major Vascular Events in NSCLC Patients Treated with Gemcitabine & Cisplatin (PubMed)
Prospective study published in the January 2005 issue of Cancer that found vascular events (coagulation disorders, thrombosis) to be common occurrences in NSCLC patients treated with chemotherapy. Strategies to predict the occurrence of vascular events should be developed to spare this life-threatening toxicity. [1/05]

V/Q (Ventilation/Perfusion) Scan Information (Lung Cancer Online)